Home Cart Sign in  
HazMat Fee +

There will be a HazMat fee per item when shipping a dangerous goods. The HazMat fee will be charged to your UPS/DHL/FedEx collect account or added to the invoice unless the package is shipped via Ground service. Ship by air in Excepted Quantity (each bottle), which is up to 1g/1mL for class 6.1 packing group I or II, and up to 25g/25ml for all other HazMat items.

Type HazMat fee for 500 gram (Estimated)
Excepted Quantity USD 0.00
Limited Quantity USD 15-60
Inaccessible (Haz class 6.1), Domestic USD 80+
Inaccessible (Haz class 6.1), International USD 150+
Accessible (Haz class 3, 4, 5 or 8), Domestic USD 100+
Accessible (Haz class 3, 4, 5 or 8), International USD 200+
Chemical Structure| 6914-79-0 Chemical Structure| 6914-79-0

Structure of 6914-79-0

Chemical Structure| 6914-79-0

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of [ 6914-79-0 ]

CAS No. :6914-79-0
Formula : C5H5NO2
M.W : 111.10
SMILES Code : OC(=O)C1(CC1)C#N
MDL No. :MFCD00190651
InChI Key :KSJJMSKNZVXAND-UHFFFAOYSA-N
Pubchem ID :2733259

Safety of [ 6914-79-0 ]

GHS Pictogram:
Signal Word:Danger
Hazard Statements:H302+H312+H332-H314
Precautionary Statements:P280-P305+P351+P338-P310
Class:8
UN#:3261
Packing Group:

Computational Chemistry of [ 6914-79-0 ] Show Less

Physicochemical Properties

Num. heavy atoms 8
Num. arom. heavy atoms 0
Fraction Csp3 0.6
Num. rotatable bonds 1
Num. H-bond acceptors 3.0
Num. H-bond donors 1.0
Molar Refractivity 25.3
TPSA ?

Topological Polar Surface Area: Calculated from
Ertl P. et al. 2000 J. Med. Chem.

61.09 Ų

Lipophilicity

Log Po/w (iLOGP)?

iLOGP: in-house physics-based method implemented from
Daina A et al. 2014 J. Chem. Inf. Model.

0.72
Log Po/w (XLOGP3)?

XLOGP3: Atomistic and knowledge-based method calculated by
XLOGP program, version 3.2.2, courtesy of CCBG, Shanghai Institute of Organic Chemistry

0.02
Log Po/w (WLOGP)?

WLOGP: Atomistic method implemented from
Wildman SA and Crippen GM. 1999 J. Chem. Inf. Model.

0.31
Log Po/w (MLOGP)?

MLOGP: Topological method implemented from
Moriguchi I. et al. 1992 Chem. Pharm. Bull.
Moriguchi I. et al. 1994 Chem. Pharm. Bull.
Lipinski PA. et al. 2001 Adv. Drug. Deliv. Rev.

-0.48
Log Po/w (SILICOS-IT)?

SILICOS-IT: Hybrid fragmental/topological method calculated by
FILTER-IT program, version 1.0.2, courtesy of SILICOS-IT, http://www.silicos-it.com

0.41
Consensus Log Po/w?

Consensus Log Po/w: Average of all five predictions

0.19

Water Solubility

Log S (ESOL):?

ESOL: Topological method implemented from
Delaney JS. 2004 J. Chem. Inf. Model.

-0.48
Solubility 37.2 mg/ml ; 0.335 mol/l
Class?

Solubility class: Log S scale
Insoluble < -10 < Poorly < -6 < Moderately < -4 < Soluble < -2 Very < 0 < Highly

Very soluble
Log S (Ali)?

Ali: Topological method implemented from
Ali J. et al. 2012 J. Chem. Inf. Model.

-0.85
Solubility 15.5 mg/ml ; 0.14 mol/l
Class?

Solubility class: Log S scale
Insoluble < -10 < Poorly < -6 < Moderately < -4 < Soluble < -2 Very < 0 < Highly

Very soluble
Log S (SILICOS-IT)?

SILICOS-IT: Fragmental method calculated by
FILTER-IT program, version 1.0.2, courtesy of SILICOS-IT, http://www.silicos-it.com

-0.1
Solubility 88.9 mg/ml ; 0.8 mol/l
Class?

Solubility class: Log S scale
Insoluble < -10 < Poorly < -6 < Moderately < -4 < Soluble < -2 Very < 0 < Highly

Soluble

Pharmacokinetics

GI absorption?

Gatrointestinal absorption: according to the white of the BOILED-Egg

High
BBB permeant?

BBB permeation: according to the yolk of the BOILED-Egg

No
P-gp substrate?

P-glycoprotein substrate: SVM model built on 1033 molecules (training set)
and tested on 415 molecules (test set)
10-fold CV: ACC=0.72 / AUC=0.77
External: ACC=0.88 / AUC=0.94

No
CYP1A2 inhibitor?

Cytochrome P450 1A2 inhibitor: SVM model built on 9145 molecules (training set)
and tested on 3000 molecules (test set)
10-fold CV: ACC=0.83 / AUC=0.90
External: ACC=0.84 / AUC=0.91

No
CYP2C19 inhibitor?

Cytochrome P450 2C19 inhibitor: SVM model built on 9272 molecules (training set)
and tested on 3000 molecules (test set)
10-fold CV: ACC=0.80 / AUC=0.86
External: ACC=0.80 / AUC=0.87

No
CYP2C9 inhibitor?

Cytochrome P450 2C9 inhibitor: SVM model built on 5940 molecules (training set)
and tested on 2075 molecules (test set)
10-fold CV: ACC=0.78 / AUC=0.85
External: ACC=0.71 / AUC=0.81

No
CYP2D6 inhibitor?

Cytochrome P450 2D6 inhibitor: SVM model built on 3664 molecules (training set)
and tested on 1068 molecules (test set)
10-fold CV: ACC=0.79 / AUC=0.85
External: ACC=0.81 / AUC=0.87

No
CYP3A4 inhibitor?

Cytochrome P450 3A4 inhibitor: SVM model built on 7518 molecules (training set)
and tested on 2579 molecules (test set)
10-fold CV: ACC=0.77 / AUC=0.85
External: ACC=0.78 / AUC=0.86

No
Log Kp (skin permeation)?

Skin permeation: QSPR model implemented from
Potts RO and Guy RH. 1992 Pharm. Res.

-6.96 cm/s

Druglikeness

Lipinski?

Lipinski (Pfizer) filter: implemented from
Lipinski CA. et al. 2001 Adv. Drug Deliv. Rev.
MW ≤ 500
MLOGP ≤ 4.15
N or O ≤ 10
NH or OH ≤ 5

0.0
Ghose?

Ghose filter: implemented from
Ghose AK. et al. 1999 J. Comb. Chem.
160 ≤ MW ≤ 480
-0.4 ≤ WLOGP ≤ 5.6
40 ≤ MR ≤ 130
20 ≤ atoms ≤ 70

None
Veber?

Veber (GSK) filter: implemented from
Veber DF. et al. 2002 J. Med. Chem.
Rotatable bonds ≤ 10
TPSA ≤ 140

0.0
Egan?

Egan (Pharmacia) filter: implemented from
Egan WJ. et al. 2000 J. Med. Chem.
WLOGP ≤ 5.88
TPSA ≤ 131.6

0.0
Muegge?

Muegge (Bayer) filter: implemented from
Muegge I. et al. 2001 J. Med. Chem.
200 ≤ MW ≤ 600
-2 ≤ XLOGP ≤ 5
TPSA ≤ 150
Num. rings ≤ 7
Num. carbon > 4
Num. heteroatoms > 1
Num. rotatable bonds ≤ 15
H-bond acc. ≤ 10
H-bond don. ≤ 5

1.0
Bioavailability Score?

Abbott Bioavailability Score: Probability of F > 10% in rat
implemented from
Martin YC. 2005 J. Med. Chem.

0.56

Medicinal Chemistry

PAINS?

Pan Assay Interference Structures: implemented from
Baell JB. & Holloway GA. 2010 J. Med. Chem.

0.0 alert
Brenk?

Structural Alert: implemented from
Brenk R. et al. 2008 ChemMedChem

0.0 alert: heavy_metal
Leadlikeness?

Leadlikeness: implemented from
Teague SJ. 1999 Angew. Chem. Int. Ed.
250 ≤ MW ≤ 350
XLOGP ≤ 3.5
Num. rotatable bonds ≤ 7

No; 1 violation:MW<1.0
Synthetic accessibility?

Synthetic accessibility score: from 1 (very easy) to 10 (very difficult)
based on 1024 fragmental contributions (FP2) modulated by size and complexity penaties,
trained on 12'782'590 molecules and tested on 40 external molecules (r2 = 0.94)

1.2

Application In Synthesis of [ 6914-79-0 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Downstream synthetic route of [ 6914-79-0 ]

[ 6914-79-0 ] Synthesis Path-Downstream   1~39

  • 2
  • [ 6914-79-0 ]
  • [ 598-10-7 ]
  • 3
  • [ 6914-79-0 ]
  • [ 88157-18-0 ]
  • 4
  • [ 6914-79-0 ]
  • [ 100-51-6 ]
  • [ 148332-48-3 ]
  • 5
  • [ 67-56-1 ]
  • [ 6914-79-0 ]
  • [ 6914-73-4 ]
  • 6
  • [ 6914-79-0 ]
  • [ 139126-45-7 ]
  • 7
  • [ 6914-79-0 ]
  • aqueous KOH-solution [ No CAS ]
  • [ 598-10-7 ]
  • 9
  • [ 6914-79-0 ]
  • 1-trifluoromethyl-cyclopropanecarbonitrile [ No CAS ]
  • 10
  • [ 123-75-1 ]
  • [ 6914-79-0 ]
  • 1-[(1-cyanocyclopropyl)carbonyl]pyrrolidine [ No CAS ]
  • 11
  • [ 110-89-4 ]
  • [ 6914-79-0 ]
  • [ 546114-01-6 ]
  • 12
  • [ 110-91-8 ]
  • [ 6914-79-0 ]
  • 1-[(1-cyanocyclopropyl)carbonyl]morpholine [ No CAS ]
  • 13
  • [ 6914-79-0 ]
  • [ 139126-42-4 ]
YieldReaction ConditionsOperation in experiment
With thionyl chloride; In toluene; at 80℃; for 0.25h; The compound was prepared according to the procedure for Intermediate 3, starting from Intermediate 2 and 1-cyanocyclopropanecarbonyl chloride (generated in situ from 1- cyanocyclopropanecarboxylic acid and excess thionyl chloride in toluene at 800C for 15 min.). APCI-MS m/z: 576 [MH+].
With oxalyl dichloride;N,N-dimethyl-formamide; In dichloromethane; Compound 1-238[00461] To a solution of l-cyanocyclopropanecarboxylic acid (10 equiv) in dichloromethane was added oxalyl chloride (9 equiv) and catalytic N,iV-dimethylformamide. Once gas evolution ceased, this crude reaction mixture was added portion- wise to a suspension of Compound 1-107 (1 equiv) in dichloromethane/pyridine (1 :1) until complete consumption of starting material was observed by LS/MS. Purification via washing residual solid with diethyl ether following an aqueous ammonium chloride and dichloromethane workup (and subsequent concentration of organics) provided the desired compound as a yellow solid (27percent).1H NMR (400 MHz, DMSO-i/6) 9.41 (s, IH), 9.09 (d, IH), 8.04 (s, IH), 7.53 (s, IH), 7.41- 7.30 (m, IH), 7.24 (d, IH), 7.24-7.20 (m, IH), 7.11 (t, IH), 7.03 (bs, IH), 6.86 (t, IH), 5.90 (s, 2H), 1.72-1.64 (m, 4H) ppm.
With oxalyl dichloride; N,N-dimethyl-formamide; In dichloromethane; at 0℃; for 2h; [00248] To a solution of 1-cyanocyclopropanecarboxylic acid (80 mg, 0.72 mmol) and oxalyl dichloride (136 mg, 1.08 mmol) in DCM (5 mL) was added a drop of DMF at 0 °C, then the mixture was stirred for 2 h, after completion the reaction mixture solution was used for next step directly.
  • 14
  • [ 6914-79-0 ]
  • C11H7N2OCl3 [ No CAS ]
  • 15
  • [ 6914-79-0 ]
  • C11H9N2OBr [ No CAS ]
  • 17
  • [ 6914-79-0 ]
  • 1-cyano-N-(2,4-dichlorophenyl)cyclopropanecarboxamide [ No CAS ]
  • 18
  • [ 6914-79-0 ]
  • C12H12N2O [ No CAS ]
  • 19
  • [ 6914-79-0 ]
  • C11H9N2OCl [ No CAS ]
  • 20
  • [ 6914-79-0 ]
  • C7H10N2O2 [ No CAS ]
  • 21
  • [ 6914-79-0 ]
  • C12H9F3N2O [ No CAS ]
  • 22
  • [ 6914-79-0 ]
  • C11H9N2OCl [ No CAS ]
  • 23
  • [ 6914-79-0 ]
  • C12H9F3N2O [ No CAS ]
  • 24
  • [ 6914-79-0 ]
  • C12H9N2OF3 [ No CAS ]
  • 25
  • [ 6914-79-0 ]
  • C12H12N2O2 [ No CAS ]
  • 26
  • [ 6914-79-0 ]
  • 1-cyano-N-p-tolylcyclopropanecarboxamide [ No CAS ]
  • 27
  • [ 6914-79-0 ]
  • 1-cyano-N-(4-bromophenyl)cyclopropanecarboxamide [ No CAS ]
  • 29
  • [ 6914-79-0 ]
  • [ 223763-93-7 ]
  • 30
  • [ 6914-79-0 ]
  • [ 457884-75-2 ]
  • 31
  • [ 6914-79-0 ]
  • (E)-(6S,9S,15R)-15-(3-Chloro-4-methoxy-benzyl)-6-isobutyl-9-[(S)-1-(3-phenyl-oxiranyl)-ethyl]-5,8-dioxa-14,17-diaza-spiro[2.15]octadec-11-ene-4,7,13,16-tetraone [ No CAS ]
  • 32
  • [ 6914-79-0 ]
  • [ 223763-98-2 ]
  • 33
  • [ 6914-79-0 ]
  • (E)-(6S,9S,15R)-15-(3-Chloro-4-methoxy-benzyl)-6-isobutyl-9-[(S)-1-(3-phenyl-oxiranyl)-ethyl]-8-oxa-5,14,17-triaza-spiro[2.15]octadec-11-ene-4,7,13,16-tetraone [ No CAS ]
  • 34
  • [ 6914-79-0 ]
  • [ 204376-54-5 ]
  • 35
  • [ 6914-79-0 ]
  • (E)-(6S,9S,15R)-15-(3-Chloro-4-methoxy-benzyl)-6-isobutyl-9-[(S)-1-((2R,3R)-3-phenyl-oxiranyl)-ethyl]-5,8-dioxa-14,17-diaza-spiro[2.15]octadec-11-ene-4,7,13,16-tetraone [ No CAS ]
  • 36
  • [ 6914-79-0 ]
  • [ 204376-52-3 ]
  • 37
  • [ 6914-79-0 ]
  • (E)-(6S,9S,15R)-9-((1R,2S,3R)-3-Chloro-2-hydroxy-1-methyl-3-phenyl-propyl)-15-(3-chloro-4-methoxy-benzyl)-6-isobutyl-5,8-dioxa-14,17-diaza-spiro[2.15]octadec-11-ene-4,7,13,16-tetraone [ No CAS ]
  • 38
  • [ 6914-79-0 ]
  • [ 223764-03-2 ]
  • 39
  • [ 6914-79-0 ]
  • (E)-(6S,9S,15R)-9-((1R,2S,3R)-3-Chloro-2-hydroxy-1-methyl-3-phenyl-propyl)-15-(3-chloro-4-methoxy-benzyl)-6-isobutyl-8-oxa-5,14,17-triaza-spiro[2.15]octadec-11-ene-4,7,13,16-tetraone [ No CAS ]
 

Historical Records

Technical Information

Categories

Related Functional Groups of
[ 6914-79-0 ]

Aliphatic Cyclic Hydrocarbons

Chemical Structure| 15177-68-1

A337467 [15177-68-1]

Trans-4-cyanocyclohexanecarboxylic acid

Similarity: 0.81

Chemical Structure| 28246-87-9

A416279 [28246-87-9]

Ethyl 1-cyanocyclobutanecarboxylate

Similarity: 0.74

Chemical Structure| 54202-05-0

A133930 [54202-05-0]

Methyl 4-cyanobicyclo[2.2.2]octane-1-carboxylate

Similarity: 0.72

Chemical Structure| 15641-58-4

A243676 [15641-58-4]

2,2,3,3-Tetramethylcyclopropanecarboxylic acid

Similarity: 0.70

Chemical Structure| 75885-59-5

A427430 [75885-59-5]

2,2-Dimethylcyclopropanecarboxylic acid

Similarity: 0.70

Carboxylic Acids

Chemical Structure| 15177-68-1

A337467 [15177-68-1]

Trans-4-cyanocyclohexanecarboxylic acid

Similarity: 0.81

Chemical Structure| 848821-06-7

A681974 [848821-06-7]

4-Cyanotetrahydro-2H-pyran-4-carboxylic acid

Similarity: 0.80

Chemical Structure| 22426-30-8

A105950 [22426-30-8]

2-Cyano-2-methylpropanoic acid

Similarity: 0.79

Chemical Structure| 632-07-5

A134730 [632-07-5]

2-Cyanopropanoic acid

Similarity: 0.76

Chemical Structure| 15641-58-4

A243676 [15641-58-4]

2,2,3,3-Tetramethylcyclopropanecarboxylic acid

Similarity: 0.70

Nitriles

Chemical Structure| 15177-68-1

A337467 [15177-68-1]

Trans-4-cyanocyclohexanecarboxylic acid

Similarity: 0.81

Chemical Structure| 848821-06-7

A681974 [848821-06-7]

4-Cyanotetrahydro-2H-pyran-4-carboxylic acid

Similarity: 0.80

Chemical Structure| 6283-71-2

A369048 [6283-71-2]

Dimethyl 2-cyanosuccinate

Similarity: 0.79

Chemical Structure| 22426-30-8

A105950 [22426-30-8]

2-Cyano-2-methylpropanoic acid

Similarity: 0.79

Chemical Structure| 632-07-5

A134730 [632-07-5]

2-Cyanopropanoic acid

Similarity: 0.76